Sam Jackson

Sam Jackson

Company: Neuron23

Job title: Chief Medical Officer

Seminars:

Strategies in Patient Selection for Your Therapeutic: Applying Biomarker Advances to Identify Appropriate Pathology by Target 11:15 am

Combining data science and genetics expertise to identify patients most likely to respond to treatment Constructing patient selection algorithms using public and private data sets Applying technology to ‘Phase 0’ trials of LRRK2Read more

day: Day One Track B AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.